Comedy stars unite for ‘Shake with Laughter’

Perspectives

Author: Joe McAweaneyPublished: 11 October 2017

Prep: Cook: Serves:

‘Shake with Laughter’ – a Parkinson’s comedy fundraiser featuring Rob Deering and Tim Vine – will be performed at London’s iconic Comedy Store on 16 October

On 16 October The Comedy Store, London, UK, will play host to the sixth edition of the Parkinson’s fundraiser ‘Shake with Laughter’.

The annual comedy show, from which all proceeds go to charity Parkinson’s UK, will feature comedians including Rob Deering, Gary Delaney, Lucy Porter, Paul Mayhew-Archer and Tim Vine.

‘Shake with Laughter’ launched in London in 2012 and has since been held in Manchester and Newcastle, with plans to debut in Glasgow next month.

Rob Deering, whose father has Parkinson’s, is a longstanding fundraiser for Parkinson’s UK. The popular stand-up has participated in marathons, comedy events and celebrity quiz shows including Pointless and The Weakest Link. He is currently on track to reach his £100,000 fundraising target over 10 years.

For more information about the event and the comedians taking part, you can visit the Parkinson’s UK website here.

Read more: October 2017 events

Diana Levine: taking photos for a cure

Last Month

Next Month

Go Back

Share this story

Comments

Episodes

Podcast roundup: conversations on the reality of Parkinson’s

A roundup of the Parkinson’s Life podcast

Over 1/3 of patients don’t receive enough info about Parkinson’s at diagnosis

Parkinson’s UK outlines key areas for improvement in care in audit

The life and work of John McLean

A tribute to the artist living with Parkinson’s who died last month

Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?

A new study suggests that regular use of non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen may lower the risk of Parkinson’s associated with mutations of the LRRK2 gene – a common genetic cause of the condition. As part of the study, researchers analysed the data for 577 individuals with the LRRK2 gene mutation. They found that regular use of aspirin and ibuprofen – at least two pills per week for at least six months – was more prevalent in people who did not have Parkinson’s compared to those with the condition. Across the study, the use of NSAIDs corresponded with roughly a 66% decrease in the risk of Parkinson’s. The researchers say that “the results of this study suggest that the regular use of NSAID medication may lower the risk for Parkinson’s among LRRK2 variant carriers … for both ibuprofen and aspirin” but more research will need to be…

US hospital initiative improves on-time administration of Parkinson’s medication

Late or missed doses of Parkinson’s medication in hospitals can lead to longer stays and greater morbidity. To counteract this issue, a team of healthcare professionals in the US launched a project to improve the on-time administration of levodopa to people with Parkinson’s. As part of the initiative – published in the Journal of Parkinson’s Disease – several measures were implemented, including electronic alerts for nurses, stocking automated medication dispensing machines with carbidopa-levodopa products, reporting to nurse unit managers on timeliness of medication administration and more. Dr Martha A Nance, the project’s lead investigator, said: “This project was very rewarding for our team, because of its obvious, immediate, and important impact on patient care. “We have reason to think that timely administration of carbidopa-levodopa may be associated with shorter stays and better outcomes and satisfaction. Anecdotally, patients have reported being surprised and pleased that nurses were reminding them that medication…

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

Researchers in France have found that deep brain stimulation for Parkinson’s may not increase the risk of developing dementia. As part of the study – published by the American Academy of Neurology – researchers identified 175 people with Parkinson’s and an average age of 56, who had deep brain stimulation. The individuals were assessed over a period of 10 years to determine if they had developed dementia. After one year, four individuals had developed dementia. After five years, 142 people from the original group were available for testing, 12 of whom had dementia. After 10 years, 104 people were available for testing, 31 of whom had dementia. Dr Elena Moro, author of the study, said: “These results are very encouraging for people with Parkinson’s and their families that they can take advantage of the benefits of deep brain stimulation without worrying about it increasing the likelihood of developing dementia.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Comedy stars unite for ‘Shake with Laughter’

Perspectives

Author: Joe McAweaneyPublished: 11 October 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Episodes

Podcast roundup: conversations on the reality of Parkinson’s

PD in Practice

Over 1/3 of patients don’t receive enough info about Parkinson’s at diagnosis

Global update

The life and work of John McLean

Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?

US hospital initiative improves on-time administration of Parkinson’s medication

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

{title}

Subscribe

Comedy stars unite for ‘Shake with Laughter’

Perspectives

Author: Joe McAweaneyPublished: 11 October 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Episodes

Podcast roundup: conversations on the reality of Parkinson’s

PD in Practice

Over 1/3 of patients don’t receive enough info about Parkinson’s at diagnosis

Global update

The life and work of John McLean

Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?

US hospital initiative improves on-time administration of Parkinson’s medication

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

{title}

Subscribe

Sign in